Co-amoxiclav 200/28.5 mg/5 ml Powder for Oral Suspension, 60 ml
Co-amoxiclav 200/28.5 mg/5 ml Powder for Oral Suspension, 60 ml — Antibiotics & Anti-infectives, as a powder for oral suspension, available for private-label manufacture from 10,000 units, produced in India. Below, the active substance of this Antibiotics & Anti-infectives product appears under its International Nonproprietary Name, with the strength per unit that the specification gives.
| Dosage form | Powder for oral suspension |
|---|---|
| Pack | 60 ml (HDPE bottle) |
| Minimum order | 10,000 units |
| Manufactured in | India |
| Registration | Not yet registered in Iraq — product open for exclusive registration in your name |
| Market status | Choose your market: Iraq · Gulf · EuropeIraq: the registration status is in the row above.Gulf: on offer for the Gulf states. The Gulf pageEurope: on offer for European buyers. Details |
| Documents | Certificate of Analysis, Certificate of Origin, Certificate of Conformity, Free Sale Certificate and MSDS — available on request. |
| Products Library | Open this formulation's card (F2021) |
About this formulation
This formulation, “Co-amoxiclav 200/28.5 mg/5 ml Powder for Oral Suspension, 60 ml”, belongs to the Antibiotics & Anti-infectives range; it is made in India for private-label brands from 10,000 units per SKU. Our production site is not yet registered in Iraq, so the product is open for registration in your name. The production time is set in our offer for this product. Declared actives include Amoxicillin 200 mg and Clavulanic acid 28.5 mg (as potassium clavulanate).
The Antibiotics & Anti-infectives range: Clarithromycin at 250 and 500 mg, a metronidazole and spiramycin tablet for dental infection, and mupirocin ointment for impetigo open this shelf.
Related formulations
Active ingredients
- Amoxicillin 200 mg per 5 ml of reconstituted suspension
- Clavulanic acid 28.5 mg (as potassium clavulanate) per 5 ml of reconstituted suspension
Powder for oral suspension giving 200 mg amoxicillin and 28.5 mg clavulanic acid (as potassium clavulanate) per 5 ml once reconstituted with water (co-amoxiclav), an aminopenicillin antibiotic combined with a beta-lactamase inhibitor, on prescription; one 60 ml HDPE bottle.
Market status in detail
Iraq. Our production site for this line has no Iraqi file yet. The site registration comes first; the product is then filed in your name; for a medicine, with a new CPP. How filing works in Iraq
Gulf. This product is on offer for the Gulf states. Tell us the country and the quantity, and we answer with the offer and the documents we supply.
Country pages: Saudi Arabia · UAE · Kuwait · Qatar · Oman · Bahrain
Europe. This product is on offer for European buyers. Tell us the country and the quantity, and we answer with the offer and the documents we supply.
Change market: Iraq · Gulf · Europe · All markets
Shipping and document legalisation for your country are calculated separately and stated in the offer.